Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading U.S. provider of consumer products in cannabis, with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a vertically integrated, high-growth cannabis operator known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf currently operates in 23 states with 96 dispensaries, 23 cultivation sites and over 30 processing sites, and employs over 3,800 team members across the United States. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information please visit www.curaleaf.com.
Company profile
Ticker
CURLF, CURA
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
LEAD VENTURES INC.
SEC CIK
Corporate docs
Latest filings (excl ownership)
6-K
Current report (foreign)
12 Sep 23
6-K
Current report (foreign)
11 Aug 23
6-K
Unaudited Condensed Interim Consolidated Financial Statements
9 Aug 23
6-K
Current report (foreign)
9 Aug 23
6-K
Curaleaf to Report Second Quarter 2023 Financial and Operational Results
18 Jul 23
6-K
Current report (foreign)
10 Jul 23
6-K
Current report (foreign)
15 Jun 23
6-K
Current report (foreign)
8 Jun 23
6-K
Unaudited Condensed Interim Consolidated Financial Statements
18 May 23
6-K
Monthly Progress Report
5 May 23
Transcripts
CURLF
Earnings call transcript
2022 Q3
8 Nov 22
CURLF
Earnings call transcript
2022 Q2
9 Aug 22
CURLF
Earnings call transcript
2022 Q1
10 May 22
CURLF
Earnings call transcript
2021 Q4
4 Mar 22
CURLF
Earnings call transcript
2021 Q3
9 Nov 21
CURLF
Earnings call transcript
2021 Q2
10 Aug 21
CURLF
Earnings call transcript
2021 Q1
11 May 21
CURLF
Earnings call transcript
2020 Q4
10 Mar 21
CURLF
Earnings call transcript
2020 Q3
18 Nov 20
Latest ownership filings
No filings
Financial summary
| Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
News
Marijuana Stock Movers For September 22, 2023
22 Sep 23
Whale Watching: Will Institutions Migrate To Cannabis Stocks?
22 Sep 23
Cannabis Stock Gainers And Losers From September 21, 2023
21 Sep 23
Russian Ties Put Alabama Cannabis Regulators In Hot Water
21 Sep 23
MSO Financial Health: Debt Restructuring Vs. Equity Raises – Analyst Digs Into Spreadsheets
21 Sep 23
Press releases
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
7 Sep 23
Curaleaf Expands Brand Portfolio With Launch of Zero Proof ™ Cannabis-Infused Drinkables
5 Sep 23
Curaleaf Celebrates Launch of Adult Use Sales at Manchester, CT Dispensary
21 Aug 23
Clever Leaves Reports Second Quarter 2023 Results
14 Aug 23
Curaleaf's Select™ Brand Expands Product Offerings With Launch of Select Liquid Diamonds
10 Aug 23